Director/PDMR Shareholding

RNS Number : 7445D
Primary Health Properties PLC
21 October 2022
 

Primary Health Properties PLC

Director's & PDMR dealings

Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investor in modern primary healthcare facilities announces the following share dealing by a  person closely associated with a Person Discharging Managerial Responsibilities ("PDMR's").

The Notification of Dealing Form for each PDMR can be found below.  This notification is made in accordance with the UK Market Abuse Regulation.

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Philippa Bateman

 

2

Reason for the notification

(a)

Position/status

PCA, being the wife of David Bateman, Chief Investment Officer and PDMR

 

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Purchase

 

(c)

Aggregated information

Price(s) and volume(s)

Price(s)

Volume(s)

£1.046

7,712

(d)

Aggregated volume price

Single transaction

£7,499.04

 

(e)

Date of transaction

21 October 2022

 

(f)

Place of transaction

London Stock Exchange (xlon)

 

 

For further information

Primary Health Properties PLC

 

Paul Wright, Company Secretary

+44(0) 203 833 3344

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBBDGGGDDGDB
UK 100